Researchers confirm two new prognostic markers for triple negative breast cancer

[News]

Physicians who treat patients with triple negative breast cancer have two new ways to predict which patients may benefit most from the well-established post-surgery treatment known as AC chemotherapy, short for adjuvant doxorubicin and cyclophosphamide.

More... (https://www.news-medical.net/news/20191205/Researchers-confirm-two-new-prognostic-markers-for-triple-negative-breast-cancer.aspx)